Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Cash Flow Reinvestment Rate
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd cash flow reinvestment rate. Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Cash Flow Reinvestment Rate of 7.80x as of December 2024, reinvesting CN¥187.51 Million (capex CN¥187.14 Million plus investments CN¥369.80K) from operating cash flow of CN¥24.04 Million. Explore Hunan Dajiaweikang Pharmaceutical Indust (301126) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Cash flow reinvestment rate of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2024. Historical reinvestment intensity for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 3 annual periods. Explore 301126 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Cash Flow Reinvestment Rate by Year (2019–2024)
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd cash flow reinvestment rate by year from 2019 to 2024. Year-by-year capital reinvestment analysis for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. For the full cash flow conversion analysis, see Hunan Dajiaweikang Pharmaceutical Indust cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.80x | CN¥187.51 Million | CN¥24.04 Million | CN¥187.14 Million | ▼ -9.7% |
| 2023 | 8.64x | CN¥234.43 Million | CN¥27.13 Million | CN¥226.70 Million | ▲ +1706.6% |
| 2019 | 0.48x | CN¥65.01 Million | CN¥135.91 Million | CN¥32.50 Million | — |